Literature DB >> 2666817

The molecular pathology of the serpins.

R W Carrell1, K S Aulak, M C Owen.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2666817

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN： 0735-1313


× No keyword cloud information.
  9 in total

1.  The molecular structure and pathology of alpha 1-antitrypsin.

Authors:  R W Carell
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

Authors:  R G Crystal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.

Authors:  K S Aulak; A E Davis; V H Donaldson; R A Harrison
Journal:  Protein Sci       Date:  1993-05       Impact factor: 6.725

4.  Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency.

Authors:  D Vidaud; J Emmerich; M Alhenc-Gelas; J Yvart; J N Fiessinger; M Aiach
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

5.  The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.

Authors:  R C Austin; W P Sheffield; R A Rachubinski; M A Blajchman
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

6.  Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin.

Authors:  Yuan-Ping Han; Chunli Yan; Warren L Garner
Journal:  J Invest Dermatol       Date:  2008-04-10       Impact factor: 8.551

7.  The murine Spi-2 proteinase inhibitor locus: a multigene family with a hypervariable reactive site domain.

Authors:  J D Inglis; R E Hill
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

8.  An RNA structure-mediated, posttranscriptional model of human α-1-antitrypsin expression.

Authors:  Meredith Corley; Amanda Solem; Gabriela Phillips; Lela Lackey; Benjamin Ziehr; Heather A Vincent; Anthony M Mustoe; Silvia B V Ramos; Kevin M Weeks; Nathaniel J Moorman; Alain Laederach
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

9.  SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway.

Authors:  Ye Song; Zhuo Li; Lei Li; Houming Zhou; Ting-Ting Zeng; Chuan Jin; Jin-Rong Lin; Sha Gao; Yan Li; Xin-Yuan Guan; Ying-Hui Zhu
Journal:  J Hepatocell Carcinoma       Date:  2021-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.